Reuters UK Business

BRUSSELS (Reuters) – Pfizer’s $43 billion bid for Seagen will be decided by EU antitrust regulators by Oct. 19, a regulatory filing showed on Friday. U.S. pharmaceutical company Pfizer announced the deal, its biggest, in March for Washington-based Seagen, a pioneer of antibody-drug conjugates, which work like “guided missiles” designed to destroy cancer while sparing …

EU antitrust regulators set Oct. 19 deadline for Pfizer’s Seagen deal Read More »

(Reuters) -A group of international bond investors is drawing up plans to sue Switzerland in the U.S. courts for expropriation over the losses they suffered after UBS agreed to take over Credit Suisse with state support, the Financial Times reported. The case is being brought together by law firm Quinn Emanuel and could be filed …

Credit Suisse bond investors plot lawsuit against Switzerland- FT Read More »

(Reuters) – German premium footwear maker Birkenstock Holding’s revenue jumped 21% in the nine months ended June 30, it said in updated paperwork for a U.S. stock market listing on Friday. The company, backed by private equity firm L Catterton, is one of a handful of high-profile firms gearing up for a stock market debut. …

Birkenstock reveals 21% revenue jump in updated financials ahead of IPO Read More »

LISBON (Reuters) – Volkswagen’s Autoeuropa plant in Portugal will resume limited production in early October, sooner than expected, after it was halted on Sept. 12 due to a shortage of auto parts, a letter to workers seen by Reuters said. Autoeuropa, which mainly produces the T-Roc compact crossover sports utility model, had previously announced a …

Portugal’s VW plant to resume production in October, ahead of schedule Read More »

(Reuters) – The European Central Bank should not raise interest rates any further, French Finance Minister Bruno Le Maire said in an interview to Bloomberg News on Friday. “We are on the right track to reduce inflation,” Le Maire said. (Reporting by Gursimran Kaur in Bengaluru; Editing by Andrew Heavens)